Geode Capital Management’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-2,587,857
Closed -$63M – 4800
2023
Q1
$63M Buy
2,587,857
+172,028
+7% +$3.77M 0.01% 1018
2022
Q4
$51.7M Buy
2,415,829
+355,148
+17% +$7.58M 0.01% 1124
2022
Q3
$37M Buy
2,060,681
+74,646
+4% +$980K 0.01% 1304
2022
Q2
$19.1M Sell
1,986,035
-4,572
-0.2% -$57.4K ﹤0.01% 1804
2022
Q1
$33.5M Buy
1,990,607
+11,196
+0.6% +$165K ﹤0.01% 1540
2021
Q4
$33.1M Buy
1,979,411
+343,337
+21% +$5.63M ﹤0.01% 1615
2021
Q3
$26.6M Buy
1,636,074
+189,008
+13% +$2.06M ﹤0.01% 1761
2021
Q2
$9.13M Buy
1,447,066
+112,086
+8% +$723K ﹤0.01% 2519
2021
Q1
$8.25M Buy
1,334,980
+186,427
+16% +$1.13M ﹤0.01% 2490
2020
Q4
$7.94M Buy
1,148,553
+84,400
+8% +$540K ﹤0.01% 2319
2020
Q3
$6M Buy
1,064,153
+499,350
+88% +$2.38M ﹤0.01% 2284
2020
Q2
$2.88M Buy
564,803
+284,630
+102% +$1.19M ﹤0.01% 2637
2020
Q1
$963K Buy
280,173
+64,464
+30% +$377K ﹤0.01% 3038
2019
Q4
$1.85M Buy
215,709
+41,935
+24% +$150K ﹤0.01% 3039
2019
Q3
$194K Hold
173,774
– – ﹤0.01% 3778
2019
Q2
$225K Hold
173,774
– – ﹤0.01% 3759
2019
Q1
$245K Hold
173,774
– – ﹤0.01% 3672
2018
Q4
$208K Hold
173,774
– – ﹤0.01% 3663
2018
Q3
$410K Hold
173,774
– – ﹤0.01% 3538
2018
Q2
$474K Hold
173,774
– – ﹤0.01% 3464
2018
Q1
$476K Hold
173,774
– – ﹤0.01% 3419
2017
Q4
$542K Sell
173,774
-12,779
-7% -$35.9K ﹤0.01% 3327
2017
Q3
$526K Hold
186,553
– – ﹤0.01% 3339
2017
Q2
$477K Sell
186,553
-54,018
-22% -$147K ﹤0.01% 3372
2017
Q1
$880K Buy
240,571
+7,501
+3% +$31.7K ﹤0.01% 3078
2016
Q4
$1.12M Buy
233,070
+8,789
+4% +$261K ﹤0.01% 2932
2016
Q3
$10.3M Sell
224,281
-181
-0.1% -$10.2K 0.01% 1474
2016
Q2
$11.5M Buy
224,462
+16,250
+8% +$807K 0.01% 1337
2016
Q1
$8.8M Sell
208,212
-2,414
-1% -$123K ﹤0.01% 1479
2015
Q4
$16.5M Buy
210,626
+10,390
+5% +$601K 0.01% 1020
2015
Q3
$8.11M Buy
200,236
+99,517
+99% +$5.27M ﹤0.01% 1484
2015
Q2
$5.24M Buy
100,719
+16,654
+20% +$828K ﹤0.01% 1857
2015
Q1
$3.91M Buy
84,065
+2,066
+3% +$107K ﹤0.01% 2007
2014
Q4
$3.68M Buy
81,999
+3,222
+4% +$135K ﹤0.01% 2014
2014
Q3
$3.07M Buy
78,777
+1,481
+2% +$58.1K ﹤0.01% 2097
2014
Q2
$3.27M Buy
77,296
+14,655
+23% +$538K ﹤0.01% 2076
2014
Q1
$2.24M Buy
62,641
+7,679
+14% +$259K ﹤0.01% 2269
2013
Q4
$1.78M Buy
+54,962
New +$1.63M ﹤0.01% 2371

Other funds holding ISEE

Geode Capital Management's ISEE Position: Q2 2023 in Review

Geode Capital Management sold out of IVERIC bio (ISEE) in Q2 2023, closing a stake of 2,587,857 shares — an estimated $63M sold.

Geode Capital Management first reported a position in ISEE in Q4 2013 and held it in 38 quarters. The position peaked at $63M in Q1 2023. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Geode Capital Management reported no remaining IVERIC bio position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 2,587,857 IVERIC bio shares in Q2 2023, an estimated $63M.
  • Geode Capital Management first reported a position in IVERIC bio in Q4 2013 and held it in 38 quarters.
  • Geode Capital Management's IVERIC bio position peaked at $63M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held IVERIC bio as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.